Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Loic Gazoppi"'
Autor:
Christelle Bonnetaud, Olivier Castelnau, Marius Ilie, Sylvie Leroy, Jonathan Benzaquen, Florian Cattet, Florence de Fraipont, Charles-Hugo Marquette, Simon Heeke, Fabrice Barlesi, Georges Garnier, Michel Poudenx, Charlotte Cohen, Isabelle Nanni, Lydia Ribeyre, Elodie Long-Mira, Loic Gazoppi, Carole Salacroup, Sandra Lassalle, Maryline Allegra, Paul Hofman, Marc G. Denis, Virginie Tanga, Julien Fayada, Jean-Philippe Berthet, Véronique Hofman
Publikováno v:
Clinical Lung Cancer
Clinical Lung Cancer, Elsevier, 2020, 21 (1), pp.56-65.e8. ⟨10.1016/j.cllc.2019.07.010⟩
Clinical Lung Cancer, Elsevier, 2020, 21 (1), pp.56-65.e8. ⟨10.1016/j.cllc.2019.07.010⟩
International audience; Background - The introduction of liquid biopsy using PCR-based assays into routine practice has had a strong impact on the treatment of EGFR-mutated lung adenocarcinoma and is now commonly used for routine testing of EGFR muta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79d43975377021fcf6b14fbc0da031db
https://hal.archives-ouvertes.fr/hal-02528403
https://hal.archives-ouvertes.fr/hal-02528403
Autor:
Pascal Boucher, Virginie Tanga, Emmanuelle Gormally, Marius Ilie, Kevin Washetine, Véronique Hofman, Eric Selva, Taycir Skhiri, Charles-Hugo Marquette, Mehdi Kara-Borni, Sandra Lassalle, Paul Hofman, Charlotte Cohen, Coraline Bence, Simon Heeke, Elodie Long-Mira, Catherine Butori, Bruno Clément, Georges Dagher, Jean-Marc Félix, Jérôme Mouroux, Christelle Bonnetaud, Loic Gazoppi
Publikováno v:
Cancers
Cancers, 2018, 10 (7), pp.E220. ⟨10.3390/cancers10070220⟩
Cancers, MDPI, 2018, 10 (7), pp.E220. ⟨10.3390/cancers10070220⟩
Cancers, Vol 10, Iss 7, p 220 (2018)
Cancers 7 (10), . (2018)
Volume 10
Issue 7
Cancers, 2018, 10 (7), pp.E220. ⟨10.3390/cancers10070220⟩
Cancers, MDPI, 2018, 10 (7), pp.E220. ⟨10.3390/cancers10070220⟩
Cancers, Vol 10, Iss 7, p 220 (2018)
Cancers 7 (10), . (2018)
Volume 10
Issue 7
International audience; Lung cancer is the major cause of death from cancer in the world and its incidence is increasing in women. Despite the progress made in developing immunotherapies and therapies targeting genomic alterations, improvement in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500094d903ae4f083c461c2d020c0cc0
https://doi.org/10.3390/cancers10070220
https://doi.org/10.3390/cancers10070220
